Cargando…
Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
Advanced diffusion imaging which accounts for complex tissue properties, such as crossing fibers and extracellular fluid, may detect longitudinal changes in widespread pathology in atypical Parkinsonian syndromes. We implemented fixel-based analysis, Neurite Orientation and Density Imaging (NODDI),...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062732/ https://www.ncbi.nlm.nih.gov/pubmed/35489192 http://dx.doi.org/10.1016/j.nicl.2022.103022 |
_version_ | 1784699013546639360 |
---|---|
author | Mitchell, Trina Wilkes, Bradley J. Archer, Derek B. Chu, Winston T. Coombes, Stephen A. Lai, Song McFarland, Nikolaus R. Okun, Michael S. Black, Mieniecia L. Herschel, Ellen Simuni, Tanya Comella, Cynthia Afshari, Mitra Xie, Tao Li, Hong Parrish, Todd B. Kurani, Ajay S. Corcos, Daniel M. Vaillancourt, David E. |
author_facet | Mitchell, Trina Wilkes, Bradley J. Archer, Derek B. Chu, Winston T. Coombes, Stephen A. Lai, Song McFarland, Nikolaus R. Okun, Michael S. Black, Mieniecia L. Herschel, Ellen Simuni, Tanya Comella, Cynthia Afshari, Mitra Xie, Tao Li, Hong Parrish, Todd B. Kurani, Ajay S. Corcos, Daniel M. Vaillancourt, David E. |
author_sort | Mitchell, Trina |
collection | PubMed |
description | Advanced diffusion imaging which accounts for complex tissue properties, such as crossing fibers and extracellular fluid, may detect longitudinal changes in widespread pathology in atypical Parkinsonian syndromes. We implemented fixel-based analysis, Neurite Orientation and Density Imaging (NODDI), and free-water imaging in Parkinson’s disease (PD), multiple system atrophy (MSAp), progressive supranuclear palsy (PSP), and controls longitudinally over one year. Further, we used these three advanced diffusion imaging techniques to investigate longitudinal progression-related effects in key white matter tracts and gray matter regions in PD and two common atypical Parkinsonian disorders. Fixel-based analysis and free-water imaging revealed longitudinal declines in a greater number of descending sensorimotor tracts in MSAp and PSP compared to PD. In contrast, only the primary motor descending sensorimotor tract had progressive decline over one year, measured by fiber density (FD), in PD compared to that in controls. PSP was characterized by longitudinal impairment in multiple transcallosal tracts (primary motor, dorsal and ventral premotor, pre-supplementary motor, and supplementary motor area) as measured by FD, whereas there were no transcallosal tracts with longitudinal FD impairment in MSAp and PD. In addition, free-water (FW) and FW-corrected fractional anisotropy (FAt) in gray matter regions showed longitudinal changes over one year in regions that have previously shown cross-sectional impairment in MSAp (putamen) and PSP (substantia nigra, putamen, subthalamic nucleus, red nucleus, and pedunculopontine nucleus). NODDI did not detect any longitudinal white matter tract progression effects and there were few effects in gray matter regions across Parkinsonian disorders. All three imaging methods were associated with change in clinical disease severity across all three Parkinsonian syndromes. These results identify novel extra-nigral and extra-striatal longitudinal progression effects in atypical Parkinsonian disorders through the application of multiple diffusion methods that are related to clinical disease progression. Moreover, the findings suggest that fixel-based analysis and free-water imaging are both particularly sensitive to these longitudinal changes in atypical Parkinsonian disorders. |
format | Online Article Text |
id | pubmed-9062732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90627322022-05-04 Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy Mitchell, Trina Wilkes, Bradley J. Archer, Derek B. Chu, Winston T. Coombes, Stephen A. Lai, Song McFarland, Nikolaus R. Okun, Michael S. Black, Mieniecia L. Herschel, Ellen Simuni, Tanya Comella, Cynthia Afshari, Mitra Xie, Tao Li, Hong Parrish, Todd B. Kurani, Ajay S. Corcos, Daniel M. Vaillancourt, David E. Neuroimage Clin Regular Article Advanced diffusion imaging which accounts for complex tissue properties, such as crossing fibers and extracellular fluid, may detect longitudinal changes in widespread pathology in atypical Parkinsonian syndromes. We implemented fixel-based analysis, Neurite Orientation and Density Imaging (NODDI), and free-water imaging in Parkinson’s disease (PD), multiple system atrophy (MSAp), progressive supranuclear palsy (PSP), and controls longitudinally over one year. Further, we used these three advanced diffusion imaging techniques to investigate longitudinal progression-related effects in key white matter tracts and gray matter regions in PD and two common atypical Parkinsonian disorders. Fixel-based analysis and free-water imaging revealed longitudinal declines in a greater number of descending sensorimotor tracts in MSAp and PSP compared to PD. In contrast, only the primary motor descending sensorimotor tract had progressive decline over one year, measured by fiber density (FD), in PD compared to that in controls. PSP was characterized by longitudinal impairment in multiple transcallosal tracts (primary motor, dorsal and ventral premotor, pre-supplementary motor, and supplementary motor area) as measured by FD, whereas there were no transcallosal tracts with longitudinal FD impairment in MSAp and PD. In addition, free-water (FW) and FW-corrected fractional anisotropy (FAt) in gray matter regions showed longitudinal changes over one year in regions that have previously shown cross-sectional impairment in MSAp (putamen) and PSP (substantia nigra, putamen, subthalamic nucleus, red nucleus, and pedunculopontine nucleus). NODDI did not detect any longitudinal white matter tract progression effects and there were few effects in gray matter regions across Parkinsonian disorders. All three imaging methods were associated with change in clinical disease severity across all three Parkinsonian syndromes. These results identify novel extra-nigral and extra-striatal longitudinal progression effects in atypical Parkinsonian disorders through the application of multiple diffusion methods that are related to clinical disease progression. Moreover, the findings suggest that fixel-based analysis and free-water imaging are both particularly sensitive to these longitudinal changes in atypical Parkinsonian disorders. Elsevier 2022-04-26 /pmc/articles/PMC9062732/ /pubmed/35489192 http://dx.doi.org/10.1016/j.nicl.2022.103022 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Regular Article Mitchell, Trina Wilkes, Bradley J. Archer, Derek B. Chu, Winston T. Coombes, Stephen A. Lai, Song McFarland, Nikolaus R. Okun, Michael S. Black, Mieniecia L. Herschel, Ellen Simuni, Tanya Comella, Cynthia Afshari, Mitra Xie, Tao Li, Hong Parrish, Todd B. Kurani, Ajay S. Corcos, Daniel M. Vaillancourt, David E. Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy |
title | Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy |
title_full | Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy |
title_fullStr | Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy |
title_full_unstemmed | Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy |
title_short | Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy |
title_sort | advanced diffusion imaging to track progression in parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062732/ https://www.ncbi.nlm.nih.gov/pubmed/35489192 http://dx.doi.org/10.1016/j.nicl.2022.103022 |
work_keys_str_mv | AT mitchelltrina advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT wilkesbradleyj advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT archerderekb advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT chuwinstont advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT coombesstephena advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT laisong advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT mcfarlandnikolausr advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT okunmichaels advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT blackmieniecial advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT herschelellen advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT simunitanya advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT comellacynthia advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT afsharimitra advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT xietao advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT lihong advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT parrishtoddb advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT kuraniajays advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT corcosdanielm advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy AT vaillancourtdavide advanceddiffusionimagingtotrackprogressioninparkinsonsdiseasemultiplesystematrophyandprogressivesupranuclearpalsy |